GedGenome™
Pan-cancer Dynamic Tracking
In the blood of cancer patients, there are often free cancer cells circulating in the blood (Circulated Tumor Cells (CTCs)) or DNA released by cell rupture (Cell-free DNA (cfDNA)). In addition to helping to understand the type of cancer and identify which treatment is appropriate for the mutation pattern, it also has the potential to analyze the metastatic status of cancer, evaluate the prognosis of survival, and even understand the appropriate drugs for individual use.
By simultaneously sequencing circulating tumor DNA and RNA in CTCs, GedGenome understands the nearly 600 gene clusters used to detect various types of cancers in bed, and can track multiple cancers, such as those in the lung, colon, uterus, and stomach, by site. By tracking the cellular and genetic behaviors of cancer cells every six months, we can keep track of the extent of cancer cell mutation, metastasis and recurrence, and prepare you for the fight against cancer.
Study of introns, exons and specific gene loci
Human genes can be broadly divided into two categories: exons, which are responsible for creating functional parts of the body, and introns, which are responsible for coordinating exon performance and ensuring accuracy of production. Genetic mutations in exons can cause the resulting parts to be shaped differently or to be less functional, allowing our bodies to do certain things differently than normal, perhaps more powerfully, or making them more susceptible to conditions (disease).
Studying the tens of millions of human exons can indeed tell us what parts of the body are failing, and together with the billions of introns that control the work of the exons, help us have a better chance of understanding what the body is more likely to do wrong (and what kind of disease). Unfortunately, most companies only offer exon studies or select only the hundreds of thousands of well-studied points (trait genes), limiting our quest to understand ourselves.
Health concerns start with your 3.2 billion genes
Complete sequencing of your personal 3.2 billion genes in one go.
Compared to other companies that test hundreds of thousands of genes (characteristic genes) or tens of millions of genes (whole genes, sometimes confusingly referred to as whole genes), our whole gene sequencing and analysis allows you to do it once and for all, once in your lifetime. As science advances in the future and human understanding of the genome becomes more and more thorough, your understanding of your body will also become more and more profound.
Personalized genetic topics, risk analysis continues to progress
With a subscription membership, we will keep your disease analysis up-to-date with modern science every year so that your understanding of your body is up-to-date.
In addition, we also provide personalized health reports based on your unique genetic profile from time to time, not only to explain your body's appearance, but also to learn more about how different genotypes affect your body's working patterns and to master the secrets of managing ourselves.
Risk management, real time knowledge
We use artificial intelligence-based genetic analysis technology to obtain the latest gene-disease association data, automatic reading of a large amount of literature and non-blinded confidence judgment ability, so that customers only need to do our whole gene sequencing analysis once, you can subscribe to real-time new knowledge of disease risk assessment services, so that you can control your future, the latest scientific development of zero time lag.
Ten major categories, 350 diseases, all at once
We use web science, combining the collective wisdom of scientists around the world and revolutionary Internet knowledge sorting techniques similar to those that built Google, to create indicators that the average consumer can understand. We also provide knowledge links to help consumers trace back to the original relevant scientific papers and make their own in-depth judgments about the credibility of their genetic risk results.
We use multiple indicators to accurately quantify your risk for disease: genome-wide association (GWAS) statistics, the incidence and frequency of risk genes, and the credibility of risk gene-related papers. In addition to quantifying disease risk levels, we also assess risk levels by ethnicity and region of residence, and perform precise analyses of multiple ethnic groups.
Biomedical artificial intelligence tools to create a foundation for digitization of biology
The Graphen Atom platform includes 12 major tools to solve difficult problems in the biomedical field. Most of the tools outperform and outperform well-known tools from the latest scientific research, while the protein structure prediction tool achieves similar performance to the most advanced tools with lower computational requirements.
Spectrum Network Computing Makes Biological Digitization More Powerful
Graphen Atom takes basic science research down to the atomic level.
These tools range from protein structure prediction, to protein-protein/protein-environment interactions, and to biological networks and systems biology perspectives. By connecting from the point, extending to the line, and then to the network, We delivers favorable performance, explainable mechanisms, and predictable results.
Like a map that can be viewed at different scales, Graphen Atom provides the basis for digital biology and helps predict and explain how biological mechanisms operate.
Report Examples
Provides 10 major categories of professionally interpreted reports
and the ability to switch between Chinese and English languages.
Invites you to understand the mystery of genetics